Last updated: 13.02.2014

Address: Main building, Archimedesweg 4-6, 2333 CN Leiden,Netherlands

Tel: +31(0) 71 519 91 00


Company description

Crucell is a global biopharmaceutical company dedicated to bringing meaningful innovation to global health. We do this by discovering, developing, manufacturing and marketing products that combat major threats to the health of people worldwide. Our specialty is fighting infectious diseases—a growing healthcare challenge.

Innovation is the drive force behind our strong research & development (R&D) pipeline, with promising products in pre-clinical and clinical development. Crucell product candidates include flu-mAb, and antibody product effective against a broad range of influenza virus strains, tuberculosis and malaria vaccines, as well as a rabies monoclonal antibody combination-all produced on our unique PER.C6® human-cell technology.

Currently we are combating twelve major infectious diseases with our range of marketed vaccines in the paediatric, travel & endemic and respiratory fields. We are the largest independent vaccine company in the world.

Products and services

Our vaccine business provides stable and predictable sales and cash flow. In 2009, we sold more than 115 million vaccine doses in over 100 countries throughout the world, which makes us the largest independent vaccine player. Within vaccines we operate in three main markets: paediatric, travel & endemic, and respiratory.


We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here